Amide derivatives as GK activators

Details for Australian Patent Application No. 2002351748 (hide)

Owner Novo Nordisk A/S

Inventors Santosh, Kalpathy Chidambareswaran; Andrews, Robert Carl; Guzel, Mustafa; Polisetti, Dharma Rao; Mjalli, Adnan M M; Kodra, Janos Tibor; Lau, Jesper

Agent Shelston IP

Pub. Number AU-B-2002351748

PCT Number PCT/DK02/00880

PCT Pub. Number WO2003/055482

Priority 02388015.6 19.02.02 EP; 60/386,185 21.12.01 US

Filing date 19 December 2002

Wipo publication date 15 July 2003

Acceptance publication date 9 July 2009

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/505 (2006.01) - Pyrimidines

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/44 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/48 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/135 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 02388015.6 19.02.02 EP; 60/386,185 21.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002351748

9 July 2009 Application Accepted

  Published as AU-B-2002351748

5 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351749-SALT COATINGS

2002351747-Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors